BioPoint SARS-CoV-2 dIgA/total antibody rapid test
Manufactured by Nanjing BioPoint Diagnostics, China - en.njbiopoint.com/index.html
Device identification number
290
CE Marking
×No
HSC common list (RAT)
×No
Format
Near POC / POC
Target type
Antibody
Commercial Status
In development
Last Update
2022-08-24 09:08:01 CET
Assay Type
Immuno-Antibody
Rapid Diagnostic
Yes
Method
Immunoassay
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements